直接抗病毒药物治疗丙型肝炎患者的建议方案及安全性
Chinese Journal of Clinical Infectious Diseases(2020)
Abstract
目前,对丙型肝炎患者的抗病毒治疗均采用直接抗病毒药物(DAAs)。由于DAAs品种较多,为方便临床医师选用,本文推荐择必达或吉利德三代(丙通沙)药物治疗,而G/P鸡尾酒(Maviret)疗法可作为其他DAAs治疗失效患者选用。文中还对这些小分子药物的安全性与耐药率作了介绍,以供参考。
MoreTranslated text
Key words
Hepatitis C,Direct-acting antiviral agents,Therapy recommendation,Safety
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined